Skip to main content
SpringerLink
Log in

Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Sequential positron emission tomographic scans with [18F]-2-fluorodeoxyglucose (PET-FDG) were performed on 14 patients with malignant gliomas. All patients had prior brain irradiation. Five patients received adjuvant eight-drugs-in-one-day chemotherapy (experimental subjects) and 9 did not (control subjects). Ratios between the maximal tumor regional cerebral metabolic rate for glucose (rCMRGlu) and the contralateral white matter rCMRGlu, the glucose uptake ratio, were determined. Percent changes in the ratio 1 day after chemotherapy in experimental subjects, and 30 days after the baseline scan in controls, were of prognostic significance. In both groups, patients with the largest percent changes in rCMRGlu had the shortest survival. In contrast, the baseline glucose uptake ratio did not predict length of survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP: Glucose utilization of cerebral gliomas measured by [1817] fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323–1329, 1982

    Google Scholar 

  2. Di Chiro G, Brooks RA, Patronas NJ, Bairamian D, Kornblith PL, Smith BH, Mansi L, Barker J: Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors. Ann Neurol 15 (suppl): S138-S146, 1984

    Google Scholar 

  3. Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M: Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62: 1074–1078, 1988

    Google Scholar 

  4. Patronas NJ, DiChiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM: Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62:816–822,1985

    Google Scholar 

  5. Cairncross JG, Warwick Pexman JH, Rathbone MP, Del Maestro RF: Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 17: 570–572, 1985

    Google Scholar 

  6. Murovic J, Turowski K, Wilson CB, Hoshino T, Levin V: Computerized tomography in the prognosis of malignant cerebral gliomas. J Neurosurg 65: 799–806, 1986

    Google Scholar 

  7. Valk PE, Budinger TF, Levin VA, Silver BA, Gutin PH, Doyle WK: PET of malignant cerebral tumors after interstitial brachytherapy. J Neurosurg 69: 830–838, 1988

    Google Scholar 

  8. Di Chiro G, Oldfield E, Wright DC, De Michele D, Katz DA, Patronas NJ, Doppman JL, Larson SM, Ito M, Kufta CV: Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors. AJR 150: 189–197, 1988

    Google Scholar 

  9. Jarden JO, Dhawan V, Poltorak A, Posner JB, Rottenberg DA: Positron emission tomographic measurement of blood-to-brain and blood-to-tumor transport of 82Rb: the effect of dexamethasone and whole-brain radiation therapy. Ann Neurol 18: 636–646, 1985

    Google Scholar 

  10. Leenders KL, Beaney RP, Brooks DJ, Lammertsma AA, Heather JD, McKenzie CG: Dexamethasone treatment of brain tumor patients: effects on regional cerebral blood flow, blood volume, and oxygen utilization. Neurology 35: 1610–1616,1985

    Google Scholar 

  11. Rozental JM, Levine RL, Nickles RJ, Dobkin JA: Glucose uptake in gliomas after treatment: a positron emission tomographic study. Arch Neurol 46: 1302–1307, 1989

    Google Scholar 

  12. Rozental JM, Levine RL, Nickles RJ, Dobkin JA: Acute change in glucose uptake by gliomas after chemotherapy. Ann Neurol 26: 182, 1989

    Google Scholar 

  13. Rozental JM, Levine RL, Dobkin JA, Nickles RJ: Acute changes in glioma metabolism after treatment. J NeuroOncol 7: S23, 1989 (abstract)

    Google Scholar 

  14. Rozental JM, Robins HI, Finlay J, Healey B, Levin AB, Steeves RA, Kohler PC, Schutta HS, Trump DL: Eightdrugs-in-one-day chemotherapy in postirradiated adult patients with malignant gliomas. Med Pediatr Oncol 17: 471–476, 1989

    Google Scholar 

  15. Rozental JM, Robins HI, Finlay J, Healey B, Levin AB, Steeves RA, Kohler PC, Schutta HS, Trump DL: Eightdrugs-in-one-day chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas. Cancer 63: 2475–2481, 1989

    Google Scholar 

  16. Steen RG: Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review. Cancer Res 49: 4075–4085, 1989

    Google Scholar 

  17. Steen RG, Tamargo RJ, McGovern KA, Sunder Rajan S, Brem H, Wehrle JP, Glickson JD: In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis (2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology. Cancer Res 48: 676–681, 1988

    Google Scholar 

  18. Li S-J, Wehrle JP, Sunder Rajan S, Steen RG, Glickson JD, Hilton J: Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy. Cancer Res 48: 4736–4742,1988

    Google Scholar 

  19. Weber G: Differential carbohydrate metabolism in tumor and host. In: Arnott MS, van Eys J, Wang YM (eds) Molecular Interrelations of Nutrition and Cancer. Raven Press, New York, pp. 191–208, 1982

    Google Scholar 

  20. Weber MJ, Salter DW, McNair TE: Increased glucose transport in malignant cells: analysis of its molecular basis. In: Arnott MS, van Eys J, Wang YM (eds) Molecular Interrelations of Nutrition and Cancer. Raven Press, New York, pp. 183–190, 1982

    Google Scholar 

  21. Dominguez JE, Graham JF, Cummins CJ, Loreck DJ, Galarraga J, Van der Feen J, De la Paz R, Smith BH: Enzymes of glucose metabolism in cultured human gliomas: neoplasia is accompanied by altered hexokinase, phosphofructokinase, and glucose-6-phosphate dehydrogenase levels. Metab Brain Disease 2: 17–30, 1987

    Google Scholar 

  22. Loreek DJ, Galarraga J, Van der Feen J, Phang JM, Smith BH, Cummins CJ: Regulation of the pentose phosphate pathway in human astrocytes and gliomas. Metab Brain Disease 2: 31–46, 1987

    Google Scholar 

  23. Evelhoch JL, Bissery M-C, Chabot GG, Simpson NE, McCoy CL, Heilbrun LK, Corbett TH: Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Res 48: 4749–4755, 1988

    Google Scholar 

  24. Naruse S, Hirakawa K, Horikawa Y, Tanaka C, Higuchi T, Ueda S, Nishikawa H, Watari H: Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for evaluation of the effects of chemotherapy. Cancer Res 45: 2429–2433, 1985

    Google Scholar 

  25. Arnold DL, Shoubridge EA, Feindel W, Villemure JG: Metabolic changes in cerebral gliomas within hours of treatment with intra-arterial BCNU demonstrated by phosphorus magnetic resonance spectroscopy. Can J Neurol Sci 14: 570–575,1987

    Google Scholar 

  26. Brooks RA, Di Chiro G, Zukerberg BW, Bairamian D, Larson SM: Test-retest studies of cerebral glucose metabolism using fluorine-18 deoxyglucose: validation of method. J Nucl Med 28: 53–59, 1987

    Google Scholar 

  27. Schefler WC: Statistics for health professionals. Addison-Wesley Publishing Company, Reading, Massachussetts, 1984, pp. 267–290

    Google Scholar 

  28. Mahaley MS: The in vitro respiration of normal brain and brain tumors. Cancer Res 26: 195–197, 1966

    Google Scholar 

  29. Tyler JL, Diksic M, Villemure J-G, Evans AC, Meyer E, Yamamoto YL, Feindel W: Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 28: 1123–1133, 1987

    Google Scholar 

  30. Hawkins R: Cerebral energy metabolism. In: McCandless DW (ed) Cerebral energy metabolism and metabolic encephalopathy. Plenum Press, New York, 1985, pp. 3–23

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology and Research Services, Wm. S. Middleton Memorial Veterans Hospital, 53705, Madison, Wisconsin

    Jack M. Rozental

  2. Departments of Neurology and Neurological Surgery, University of Wisconsin Medical School, 53792, Madison, Wisconsin

    Jack M. Rozental

  3. Neurology and Research Services, Wm. S. Middleton Memorial Veterans Hospital, 53705, Madison, Wisconsin

    Ross L. Levine

  4. Departments of Neurology and Radiology, University of Wisconsin Medical School, 53792, Madison, Wisconsin

    Ross L. Levine

  5. Departments of Medical Physics and Radiology, University of Wisconsin Medical School, 53706, Madison, WI, USA

    Robert J. Nickles

Authors
  1. Jack M. Rozental
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ross L. Levine
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert J. Nickles
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rozental, J.M., Levine, R.L. & Nickles, R.J. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance. J Neuro-Oncol 10, 75–83 (1991). https://doi.org/10.1007/BF00151248

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00151248

Key words

Search

Navigation